当前位置: X-MOL 学术PLOS Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nanog safeguards early embryogenesis against global activation of maternal β-catenin activity by interfering with TCF factors.
PLOS Biology ( IF 7.8 ) Pub Date : 2020-07-23 , DOI: 10.1371/journal.pbio.3000561
Mudan He 1, 2 , Ru Zhang 1, 2 , Shengbo Jiao 1, 2 , Fenghua Zhang 1, 2 , Ding Ye 1, 2 , Houpeng Wang 1, 2 , Yonghua Sun 1, 2
Affiliation  

Maternal β-catenin activity is essential and critical for dorsal induction and its dorsal activation has been thoroughly studied. However, how the maternal β-catenin activity is suppressed in the nondorsal cells remains poorly understood. Nanog is known to play a central role for maintenance of the pluripotency and maternal -zygotic transition (MZT). Here, we reveal a novel role of Nanog as a strong repressor of maternal β-catenin signaling to safeguard the embryo against hyperactivation of maternal β-catenin activity and hyperdorsalization. In zebrafish, knockdown of nanog at different levels led to either posteriorization or dorsalization, mimicking zygotic or maternal activation of Wnt/β-catenin activities, and the maternal zygotic mutant of nanog (MZnanog) showed strong activation of maternal β-catenin activity and hyperdorsalization. Although a constitutive activator-type Nanog (Vp16-Nanog, lacking the N terminal) perfectly rescued the MZT defects of MZnanog, it did not rescue the phenotypes resulting from β-catenin signaling activation. Mechanistically, the N terminal of Nanog directly interacts with T-cell factor (TCF) and interferes with the binding of β-catenin to TCF, thereby attenuating the transcriptional activity of β-catenin. Therefore, our study establishes a novel role for Nanog in repressing maternal β-catenin activity and demonstrates a transcriptional switch between β-catenin/TCF and Nanog/TCF complexes, which safeguards the embryo from global activation of maternal β-catenin activity.



中文翻译:

Nanog通过干扰TCF因子来保护早期胚胎发生,以抵抗母体β-catenin活性的全面激活。

母体β-catenin的活性对于背诱导是必不可少的,并且它的背激活已被深入研究。但是,如何在非背侧细胞中抑制母体β-catenin的活性仍知之甚少。已知Nanog在维持多能性和母体-合子转换(MZT)中起着核心作用。在这里,我们揭示了Nanog作为母体β-catenin信号转导的强阻遏物的新作用,以保护胚胎免受母体β-catenin活性的过度激活和超背化。在斑马鱼中,不同水平的nanog敲低导致后验或背侧化,模仿Wnt /β-catenin活性的合子或母体激活,以及nanog的母体合子突变体(MZ nanog)表现出强烈的母体β-catenin活性激活和超背化。尽管本构激活剂型Nanog(Vp16-Nanog,缺少N末端)完全挽救了MZ nanog的MZT缺陷,但它没有挽救由β-catenin信号激活产生的表型。从机制上讲,Nanog的N末端直接与T细胞因子(TCF)相互作用,并干扰β-catenin与TCF的结合,从而减弱β-catenin的转录活性。因此,我们的研究建立了Nanog抑制母体β-catenin活性的新作用,并证明了β-catenin/ TCF和Nanog / TCF复合体之间的转录转换,从而保护了胚胎免受母体β-catenin活性的整体激活。

更新日期:2020-07-24
down
wechat
bug